Stock IdeasStrong Buy StocksStrong Buy Stocks from Top Wall Street AnalystsLatest stocks with a Strong Buy rating from the top performing 25% of analysts tracked by WallStreetZen
Stock IdeasStrong Buy Stocks
| Analyst / Firm | Company | Price | Rating | Price Target | Upside/Downside | Date |
|---|---|---|---|---|---|---|
Beone Medicines LtdONC | $358.77 | Strong Buy | $445.00 | +24.03% | a day ago | |
Analyst RankingTop 9% #455 out of 5527 analysts Average Return+10.24% Win Rate58%102 out of 177 Risk vs RewardPoor Good Analyst ColorJP Morgan's Jessica Fye raised their price target on Beone Medicines (NASDAQ: ONC) by 4.7% from $425 to $445 on 2026/10/01. The analyst maintained their Strong Buy rating on the stock. BeOne Medicines is expected to report its Q3 2026 earnings on 2026/11/05. Raising their price target in a preview note, Fye headlined that Brukinsa sales continue to trend with strength. | ||||||
Tesla IncTSLA | $800.00 | Strong Buy | $850.00 | +6.25% | a day ago | |
Upgrade to Premium to View MoreStrong buys: Upgrade to Premium to view the rest of today's Strong Buy stocks from Wall Street's top analysts Already have access to Premium? Sign In | ||||||
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.